quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:56:07·681d
INSIDERFiling
Deciphera Pharmaceuticals Inc. logo

Chief Financial Officer Kelly Thomas Patrick was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)

DCPH· Deciphera Pharmaceuticals Inc.
Health Care
Original source

Companies

  • DCPH
    Deciphera Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Nov 20UpdateJP Morgan$14.00
  • Oct 30UpdatePiper Sandler$23.00
  • Aug 10UpdateStifel$20.00
  • Jan 4UpdateGuggenheim$22.00
  • Aug 29UpdateCowen$25.00
  • Aug 5UpdateJMP Securities$23.00

Related

  • SEC672d
    SEC Form 15-12G filed by Deciphera Pharmaceuticals Inc.
  • SEC679d
    SEC Form EFFECT filed by Deciphera Pharmaceuticals Inc.
  • INSIDER681d
    EVP & Chief Medical Officer Sherman Matthew L was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER681d
    SVP, Chief Development Officer Pitman Jama was granted 20,163 shares and returned 53,951 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER681d
    Director Friedman Franklin Stuart closing all direct ownership in the company (SEC Form 4)
  • INSIDER681d
    SEC Form 4 filed by Director Kelley Susan L.
  • INSIDER681d
    EVP & Chief Scientific Officer Dhanak Dashyant was granted 25,913 shares and returned 184,088 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER681d
    SEC Form 4 filed by Director Martin John Richard
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022